- Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002;96(1):1–6. doi:10.1053/rmed.2001.1207.
- Rosner M, Hanneder M, Siegel N, et al. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res. 2008;658(3):234–246. doi:10.1016/j.mrrev.2008.01.001.
- von Ranke FM, Zanetti G, Pereira e Silva JL, et al. Tuberous sclerosis complex: state-of-the-art review with a focus on pulmonary involvement. Lung. 2015;193(5):619–627. doi:10.1007/s00408-015-9750-6.
- Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243–254. doi:10.1016/j.pediatrneurol.2013.08.001.
- Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001;164(4):669–671. doi:10.1164/ajrccm.164.4.2101154.
- Astrinidis A, Khare L, Carsillo T, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000;37(1):55–57. doi:10.1136/jmg.37.1.55.
- O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004;94(6):853–857. doi:10.1111/j.1464-410X.2004.05046.x.
- Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990;323(18):1254–1260. doi:10.1056/NEJM199011013231807.
- McCormack FX, Gupta N, Finlay GR, et al; ATS/JRS Committee on Lymphangioleiomyomatosis. Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016;194(6):748–761. doi:10.1164/rccm.201607-1384ST.
- Young LR, Vandyke R, Gulleman PM, et al. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010;138(3):674–681. doi:10.1378/chest.10-0573.
- Tyburczy ME, Dies KA, Glass J, et al. Mosaic and intronic mutations in TSC1/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 2015;11(11):e1005637. doi:10.1371/journal.pgen.1005637.
- McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595–1606. doi:10.1056/NEJMoa1100391.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 4
Clinician’s Corner
A 20-year-old woman with chronic cough and dyspnea
Jiesu L. Suna Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor University Medical Center, Dallas, Texas, USACorrespondence[email protected]
https://orcid.org/0000-0002-4920-7294
, MD, MPHhttps://orcid.org/0000-0002-4920-7294, , MD, PhD, , DO, , MD, PhD, , MD & , MD